Trades Jul 25, 2023 – May 3, 2024

Issuer

HUMAHumacyte, Inc.

1 politician disclosed trades in HUMA (Humacyte, Inc.) between Jul 25, 2023 – May 3, 2024.

Trades

9

Politicians

1

Buy vol.

$89.0k

Sell vol.

$123.5k

Who disclosed trades in HUMA

A sale may close the position; filings are not a live holdings snapshot.

Senators who traded HUMA (1)

NameLast tradeBuysSellsEst. volume
Thomas H TubervilleMay 3, 202454$212.5k

Republicans who traded HUMA (1)

NameLast tradeBuysSellsEst. volume
Thomas H TubervilleMay 3, 202454$212.5k

Recent trades (9)

PoliticianTraded issuerSectorTypeSizeTraded
Trade price
Yesterday
PublishedFiled after
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcareSale$1k–$15kMay 3, 2024
$4.41
$0.53
Aug 5, 2026824 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcareSale$15k–$50kMay 3, 2024
$4.41
$0.53
Aug 5, 2026824 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcarePurchase$1k–$15kMar 21, 2024
$3.60
$0.53
Aug 5, 2026867 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcarePurchase$1k–$15kMar 21, 2024
$3.60
$0.53
Aug 5, 2026867 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcarePurchase$15k–$50kMar 21, 2024
$3.60
$0.53
Aug 5, 2026867 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcareSale$50k–$100kApr 30, 2024
$3.92
$0.53
May 15, 202415 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcarePurchase$15k–$50kFeb 12, 2024
$3.87
$0.53
Mar 15, 202432 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcareSale$1k–$15kJan 19, 2024
$2.67
$0.53
Feb 14, 202426 days
Thomas H Tuberville
Humacyte, Inc.HUMA
HealthcarePurchase$1k–$15kJul 25, 2023
$2.87
$0.53
Aug 14, 202320 days

Download HUMA congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.

RSS for HUMANew congressional filings in this symbol, by filing date.

Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.